Discovery of GW870086: a potent anti‐inflammatory steroid with a unique pharmacological profile

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Pharmacology

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.12232PMID 23639214PMCID PMC3831715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucocorticoid-induced osteoporosis

  2015influential reference
• Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial

  2012influential reference
• Anti‐inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up‐regulation of dual specificity phosphatase 1

  2012cited by this paper
• Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor.

  2012influential reference
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• M1753 Characterization of a Plant-Derived Selective Glucocorticoid Receptor Agonist (SEGRA) for the Treatment of Inflammatory Bowel Disease

  2010cited by this paper
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor

  2009influential reference
• Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases

  2009influential reference
• Dissociated non-steroidal glucocorticoid receptor modulators: an update on new compounds

  2008cited by this paper
• Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids*

  2008cited by this paper
• X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain.

  2008influential reference
• Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages.

  2008cited by this paper
• Nuclear receptors: doubling up in the lung.

  2008cited by this paper
• Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

  2007cited by this paper
• Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease.

  2007influential reference
• Dissociated non-steroidal glucocorticoids: tuning out untoward effects

  2007cited by this paper
• A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease.

  2005influential reference
• Genetic Dissection of Corticosteroid Receptor Function in Mice

  2004cited by this paper
• Treatment of inflammatory bowel disease with corticosteroids.

  2004cited by this paper
• Ciclesonide: a novel inhaled corticosteroid

  2004cited by this paper
• Corticosteroids treatment.

  2004cited by this paper
• Corticosteroids--from an idea to clinical use.

  2004cited by this paper
• Designing corticosteroid drugs for pulmonary selectivity.

  2004cited by this paper
• Inhaled corticosteroids: past lessons and future issues.

  2003cited by this paper
• Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management.

  2003influential reference
• Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments.

  2003influential reference
• Mometasone furoate is a less specific glucocorticoid than fluticasone propionate

  2002cited by this paper
• Mechanisms involved in the side effects of glucocorticoids.

  2002influential reference
• A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance1

  2002cited by this paper
• Molecular mechanisms of glucocorticoid action

  2002cited by this paper
• New Glucocorticosteroids with an improved therapeutic ratio?

  2001influential reference
• A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.

  2001cited by this paper
• Physical Interaction and Functional Synergy between Glucocorticoid Receptor and Ets2 Proteins for Transcription Activation of the Rat Cytochrome P-450c27 Promoter*

  2001cited by this paper
• Cross-talk between glucocorticoid receptor and AP-1

  2001cited by this paper
• Therapeutic Benefit of a Dissociated Glucocorticoid and the Relevance of In Vitro Separation of Transrepression from Transactivation Activity

  2001influential reference
• Glucocorticoid-induced osteoporosis.

  2000cited by this paper
• Molecular basis for corticosteroid action in asthma.

  2000cited by this paper
• [SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases].

  2000cited by this paper
• Multiple actions of steroid hormones--a focus on rapid, nongenomic effects.

  2000cited by this paper
• Safety of Inhaled and Intranasal Corticosteroids

  2000cited by this paper
• Molecular genetic dissection of glucocorticoid receptor function in vivo

  2000cited by this paper
• Molecular Genetic Analysis of Glucocorticoid Signaling Using the Cre/loxP System

  2000cited by this paper
• Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.

  1999cited by this paper
• Mechanisms of Glucocorticoid-receptor-mediated Repression of Gene Expression.

  1999cited by this paper
• Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism

  1999cited by this paper
• Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

  1998cited by this paper
• Benefits of low-dose corticosteroids in rheumatoid arthritis.

  1997cited by this paper
• Corticosteroids in the treatment of rheumatologic diseases

  1997cited by this paper
• Corticosteroids in the treatment of rheumatologic diseases.

  1996cited by this paper
• Molecular mechanisms of anti‐inflammatory action of glucocorticoids

  1996cited by this paper
• Anti-inflammation: direct physical association and functional antagonism between transcription factor NF-KB and the glucocorticoid receptor.

  1995cited by this paper
• Anti-inflammatory actions of steroids: molecular mechanisms.

  1993cited by this paper
• Corticosteroid therapy in rheumatoid arthritis.

  1990cited by this paper
• Corticosteroid therapy for rheumatoid arthritis.

  1973cited by this paper

• Isothiouronium-Mediated Conversion of Carboxylic Acids to Cyanomethyl Thioesters

  2023cites this paper
• Structure-based virtual screening, molecular docking, molecular dynamics simulation and MM/PBSA calculations towards identification of steroidal and non-steroidal selective glucocorticoid receptor modulators

  2022cites this paper
• Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment

  2022cites this paper
• Drug repositioning to propose alternative modulators for glucocorticoid receptor through structure-based virtual screening

  2021influential citation
• Glucocorticoid-induced ocular hypertension: origins and new approaches to minimize

  2020influential citation
• Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?

  2020cites this paper
• Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review

  2020cites this paper
• Dimerization of glucocorticoid receptors and its role in inflammation and immune responses.

  2020cites this paper
• Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication.

  2020cites this paper
• Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding.

  2019cites this paper
• Product Data Sheet Inhibitors • A gonists

  2018cites this paper
• GS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells

  2017cites this paper
• Hypoxia causes IL‐8 secretion, Charcot Leyden crystal formation, and suppression of corticosteroid‐induced apoptosis in human eosinophils

  2017cites this paper
• Glucocorticoid therapy and ocular hypertension.

  2016cites this paper
• Understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma – an update

  2016influential citation
• Emerging corticosteroid agonists for the treatment of asthma

  2015influential citation
• The long‐acting β2‐adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor‐mediated transcription in human airway epithelial cells in a gene‐ and agonist‐dependent manner

  2015cites this paper
• The transrepression arm of glucocorticoid receptor signaling is protective in mutant huntingtin-mediated neurodegeneration

  2015cites this paper
• Clinical Efficacy and Tolerability of a Novel Selective Corticosteroid in Atopic Dermatitis - Two Randomised Controlled Trials

  2015cites this paper
• An analysis of glucocorticoid receptor‐mediated gene expression in BEAS‐2B human airway epithelial cells identifies distinct, ligand‐directed, transcription profiles with implications for asthma therapeutics

  2015influential citation
• Glucocorticoid receptor function in health and disease

  2015cites this paper
• Correction: Cytokine-Induced Loss of Glucocorticoid Function: Effect of Kinase Inhibitors, Long-Acting β2-Adrenoceptor Agonist and Glucocorticoid Receptor Ligands

  2015cites this paper
• The novel inhaled glucocorticoid receptor agonist GW870086X protects against adenosine-induced bronchoconstriction in asthma.

  2015cites this paper
• Novel glucocorticoid receptor agonists in the treatment of asthma

  2015cites this paper
• Cytokine-Induced Loss of Glucocorticoid Function: Effect of Kinase Inhibitors, Long-Acting β2-Adrenoceptor Agonist and Glucocorticoid Receptor Ligands

  2015cites this paper
• Modelling studies of bitter taste, glucocorticoid and VEGFR2 receptors and their ligands

  2014cites this paper
• Effects of representative glucocorticoids on TNFα- and CD40L-induced NF-κB activation in sensor cells.

  2014cites this paper
• Efficacy and safety of once-daily GW870086 a novel selective glucocorticoid in mild-moderate asthmatics: a randomised, two-way crossover, controlled clinical trial

  2013cites this paper
• R esearch Progress of Glucocorticoid Receptor and New Glucocorticoid Receptor Modulators

  year unknowncites this paper